已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Tumor Recurrence After Complete Resection for Non-Small Cell Lung Cancer

医学 淋巴血管侵犯 围手术期 危险系数 比例危险模型 肺癌 阶段(地层学) 原发性肿瘤 回顾性队列研究 T级 外科 癌症 内科学 转移 置信区间 古生物学 生物
作者
Matthew D. Taylor,Alykhan S. Nagji,Castigliano M. Bhamidipati,Nicholas Theodosakis,Benjamin D. Kozower,Christine L. Lau,David R. Jones
出处
期刊:The Annals of Thoracic Surgery [Elsevier BV]
卷期号:93 (6): 1813-1821 被引量:186
标识
DOI:10.1016/j.athoracsur.2012.03.031
摘要

Long-term survival after R0 resection for non-small cell lung cancer (NSCLC) is less than 50%. The majority of mortality after resection is related to tumor recurrence. The purpose of this study was to identify independent perioperative and pathologic variables that are associated with NSCLC recurrence after complete surgical resection.A retrospective examination was performed of a prospectively maintained database of patients who underwent resection for NSCLC from July 1999 to August 2008 at a single institution. Clinicopathologic variables were evaluated for their influence on time to recurrence. Cox's proportional regression hazard model examined the association of recurrence in NSCLC.A total of 1,143 patients met inclusion criteria and had complete follow-up information. Of these patients, 378 (33.1%) had recurrence of the primary cancer. Median follow-up was 24 months (range, 3-134 months). Preoperative tumor maximum standardized uptake value (SUVmax) greater than 5 was associated with increased risk of recurrence (hazard ratio [HR], 1.81; p=0.01). Preoperative radiation was independently associated with recurrence (HR, 1.98; p=0.05) as well as the presence of pathologic stage II and stage III disease (stage II: HR, 2.53; p=0.05; stage III: HR, 6.49; p=0.006). Subgroup analysis found that sublobar resection was also associated with locoregional recurrence after resection (HR, 4.17; p=0.02) and lymphovascular invasion of distant recurrence (HR, 4.21; p=0.002).In the largest series reported to date on postresectional recurrence of NSCLC, SUVmax greater than 5, increasing pathologic stage, and the administration of preoperative radiation were independently associated with NSCLC recurrence after resection. Sublobar resection was independently associated with locoregional recurrence, and lymphovascular invasion was associated with distant recurrence.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xingsixs完成签到 ,获得积分10
1秒前
滴嘟滴嘟完成签到 ,获得积分10
2秒前
有趣的银完成签到,获得积分10
3秒前
谷歌狗发布了新的文献求助10
5秒前
5秒前
6秒前
易水完成签到,获得积分20
6秒前
6秒前
8秒前
内向的恶犬完成签到 ,获得积分10
10秒前
Lucas应助哎咦随风起采纳,获得10
11秒前
18746005898完成签到 ,获得积分10
11秒前
宇123发布了新的文献求助10
12秒前
文明8完成签到,获得积分10
15秒前
哈哈完成签到 ,获得积分10
15秒前
万能图书馆应助nadia采纳,获得150
18秒前
姆姆没买完成签到 ,获得积分0
18秒前
19秒前
Mic应助易水采纳,获得10
19秒前
和风完成签到 ,获得积分10
20秒前
能干的荆完成签到 ,获得积分10
21秒前
李雨芹发布了新的文献求助30
25秒前
唐磊完成签到,获得积分10
26秒前
科研通AI6应助coffee333采纳,获得10
26秒前
等你下课完成签到 ,获得积分10
27秒前
xiaozhou完成签到,获得积分20
29秒前
隐形曼青应助甜甜的采纳,获得10
39秒前
赘婿应助Frank采纳,获得10
39秒前
科研通AI6应助李雨芹采纳,获得10
41秒前
44秒前
迷路的台灯完成签到 ,获得积分10
46秒前
46秒前
misa完成签到 ,获得积分10
47秒前
科研通AI6应助tctc采纳,获得10
48秒前
48秒前
lige完成签到 ,获得积分10
48秒前
天外来物完成签到 ,获得积分10
49秒前
兰月满楼完成签到 ,获得积分10
49秒前
葵魁发布了新的文献求助10
51秒前
mm完成签到,获得积分20
52秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Handbook of Milkfat Fractionation Technology and Application, by Kerry E. Kaylegian and Robert C. Lindsay, AOCS Press, 1995 1000
Athena操作手册 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
Optimisation de cristallisation en solution de deux composés organiques en vue de leur purification 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5042126
求助须知:如何正确求助?哪些是违规求助? 4272714
关于积分的说明 13321555
捐赠科研通 4085380
什么是DOI,文献DOI怎么找? 2235157
邀请新用户注册赠送积分活动 1242727
关于科研通互助平台的介绍 1169563